Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Medicine Année : 2021

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study

Dates et versions

hal-03345999 , version 1 (16-09-2021)

Identifiants

Citer

Tressie Herrmann, Angeline Ginzac, Ioana Molnar, Sébastien Bailly, Xavier Durando, et al.. Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study. Cancer Medicine, In press, ⟨10.1002/cam4.4208⟩. ⟨hal-03345999⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More